Tech Company Financing Transactions
Rubicon Genomics Funding Round
Rubicon Genomics, based in Ann Arbor, secured $2 million in funding from BroadOak Capital Partners and Research Corporation Technologies.
Transaction Overview
Company Name
Announced On
7/16/2015
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
BroadOak Capital Partners (Lead Investor)
Proceeds Purpose
Rubicon sought the new financing because it's preparing to launch a new product called ThruPlex Plasma-seq this month.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4355 Varsity Dr.
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Overview
Rubicon has developed a superior test to non-invasively diagnose cancer and other diseases using its proprietary MethylPlex technology to amplify the exceedingly small amounts of abnormally-methylated DNA that are released by diseased tissue into serum and urine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Koziarz
Chief Scientific Officer
John Langmore
General Manager
Christine Haakenson
VP - Manufacturing
Takao Kurihara
VP - R & D
Emmanuel Kamberov
Browse more venture capital transactions:
Prev: 7/16/2015: Virtuix venture capital transaction
Next: 7/16/2015: Cinarra Systems venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs